CD66c is a novel marker for colorectal cancer stem cell isolation, and its silencing halts tumor growth in vivo

Combined CD133/CD44 Expression as a Prognostic Indicator of Disease-Free Survival in Patients With Colorectal Cancer

(2012) Gennaro Galizia   ARCHIVES OF SURGERY

Protein cross-talk in CD133+ colon cancer cells indicates activation of the Wnt pathway and upregulation of SRp20 that is potentially involved in tumorigenicity

(2012) Claudia Corbo et al.   PROTEOMICS

Detection of erbB2 copy number variations in plasma of patients with esophageal carcinoma

(2011) Immacolata Andolfo et al.   BMC CANCER

The Importance of the Stem Cell Marker Prominin-1/CD133 in the Uptake of Transferrin and in Iron Metabolism in Human Colon Cancer Caco-2 Cells

(2011) Erika Bourseau-Guilmain et al.   PLoS One

The Stem Cell Marker CD133 Associates with Enhanced Colony Formation and Cell Motility in Colorectal Cancer

(2010) Tarek M. A. Elsaba et al.   PLoS One

Preclinical evaluation of carcinoembryonic cell adhesion molecule (CEACAM) 6 as potential therapy target for pancreatic adenocarcinoma

(2009) Laura A Strickland et al.   JOURNAL OF PATHOLOGY

CD44 is of Functional Importance for Colorectal Cancer Stem Cells

(2008) L. Du et al.   CLINICAL CANCER RESEARCH

Cancer Stem Cell–Directed Therapies: Recent Data From the Laboratory and Clinic

(2008) Christopher Y Park et al.   MOLECULAR THERAPY

Bmi1 is expressed in vivo in intestinal stem cells

(2008) Eugenio Sangiorgi et al.   NATURE GENETICS